TipRanks
National Healthcare Properties (HLTC)
OTHER OTC:HLTC
US Market
Want to see HLTC full AI Analyst Report?

National Healthcare Properties (HLTC) AI Stock Analysis

29 Followers

Top Page

HLTC

National Healthcare Properties

(OTC:HLTC)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - Gpt-5.6Sol)
Rating:52Neutral
Price Target:
$13.00
▲(19.82% Upside)
Action:Reiterated
Date:09/11/26
Overall score is pulled down mainly by weak financial performance (volatile revenue and ongoing losses) and bearish near-term technicals, while positive corporate actions (asset sale, debt reduction, and capital optimization) and improved recent cash generation provide meaningful offset.
Positive Factors
Portfolio sale and deleveraging
The facility sale and associated debt repayment materially reduce balance-sheet leverage while releasing capital from the portfolio. Lower secured debt should improve financial flexibility, reduce funding pressure, and support a more resilient healthcare real estate platform over coming quarters.
Negative Factors
Extreme revenue contraction
A 99.4% TTM revenue decline signals severe instability in the operating base and makes future earnings and cash generation less predictable. Such contraction can weaken scale advantages, reduce recurring property income, and complicate portfolio planning over the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Portfolio sale and deleveraging
The facility sale and associated debt repayment materially reduce balance-sheet leverage while releasing capital from the portfolio. Lower secured debt should improve financial flexibility, reduce funding pressure, and support a more resilient healthcare real estate platform over coming quarters.
Read all positive factors

National Healthcare Properties (HLTC) vs. SPDR S&P 500 ETF (SPY)

National Healthcare Properties Business Overview & Revenue Model

Company Description
National Healthcare Properties, Inc. is a real estate investment trust for U.S. federal income tax purposes. The Company acquires, owns and manages a diversified portfolio of healthcare-related real estate, focused on outpatient medical facilities...

National Healthcare Properties Financial Statement Overview

Summary
Mixed fundamentals: the income statement is the primary weakness with extreme TTM revenue decline and persistent net losses, partially offset by improved leverage (debt down sharply vs. prior years) and a better TTM cash profile with positive operating and free cash flow.
Income Statement
34
Negative
Balance Sheet
46
Neutral
Cash Flow
55
Neutral
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue536.00K339.81M353.79M345.93M335.85M329.36M
Gross Profit-335.51M-33.14M132.65M128.13M122.40M123.54M
EBITDA145.40M82.02M-22.36M76.87M53.76M42.59M
Net Income-61.15M-71.07M-189.70M-72.30M-79.62M-85.18M
Balance Sheet
Total Assets1.98B1.71B1.95B2.15B2.18B2.21B
Cash, Cash Equivalents and Short-Term Investments245.69M57.62M21.65M46.41M53.65M59.74M
Total Debt380.43M380.95M1.15B1.18B1.12B1.09B
Total Liabilities919.05M1.11B1.26B1.24B1.18B1.17B
Stockholders Equity1.05B600.06M684.56M894.15M992.64M1.03B
Cash Flow
Free Cash Flow23.78M-21.77M-101.75M-773.00K302.00K19.81M
Operating Cash Flow50.75M6.95M-79.85M21.62M28.30M38.88M
Investing Cash Flow-115.13M69.81M63.97M-62.82M-41.78M-47.92M
Financing Cash Flow263.59M-42.40M-1.35M55.97M4.64M4.08M

National Healthcare Properties Technical Analysis

Technical Analysis Sentiment
Positive
Last Price10.85
Price Trends
50DMA
11.27
Positive
100DMA
10.49
Positive
200DMA
9.11
Positive
Market Momentum
MACD
0.12
Negative
RSI
92.55
Negative
STOCH
33.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HLTC, the sentiment is Positive. The current price of 10.85 is below the 20-day moving average (MA) of 10.96, below the 50-day MA of 11.27, and above the 200-day MA of 9.11, indicating a bullish trend. The MACD of 0.12 indicates Negative momentum. The RSI at 92.55 is Negative, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HLTC.

National Healthcare Properties Risk Analysis

National Healthcare Properties disclosed 86 risk factors in its most recent earnings report. National Healthcare Properties reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

National Healthcare Properties Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
$390.27M20.294.96%12.94%5.66%―
65
Neutral
$755.47M21.0972.36%4.89%18.27%6.18%
59
Neutral
$508.97M26.1612.79%8.16%0.75%7.29%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
54
Neutral
$1.87B-6.97-16.22%0.52%-1.49%7.49%
52
Neutral
$373.62M-105.96-6.25%0.00%-0.51%44.14%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HLTC
National Healthcare Properties
13.05
5.15
65.19%
DHC
Diversified Healthcare Trust
7.73
3.44
80.14%
CHCT
Community Healthcare
13.62
0.66
5.08%
UHT
Universal Health Realty Income
36.62
2.16
6.28%
STRW
Strawberry Fields REIT Inc
13.50
2.18
19.28%

National Healthcare Properties Corporate Events

Executive/Board Changes
National Healthcare Properties Announces Routine Board Resignation
Neutral
Sep 14, 2026
National Healthcare Properties, Inc. disclosed that board member Edward M. Weil, Jr. resigned from the company’s board of directors on September 11, 2026, with the resignation effective the same day. The company emphasized that Weil’s ...
Business Operations and StrategyM&A Transactions
National Healthcare Properties Completes Major Facility Portfolio Sale
Positive
Sep 10, 2026
On September 10, 2026, National Healthcare Properties completed the first tranche of a previously announced sale of a portfolio of 86 outpatient medical facilities to an unaffiliated buyer. This initial tranche comprised 30 properties and generate...
Business Operations and StrategyExecutive/Board ChangesFinancial DisclosuresPrivate Placements and Financing
National Healthcare Properties Redeems Preferred Shares, Optimizes Capital
Positive
Aug 5, 2026
In the second quarter of 2026, National Healthcare Properties completed its transition to the public markets, reporting a net loss of $0.13 per share but steady FFO per share, alongside 6.8% same-store cash NOI growth and a standout 20.1% increase...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 11, 2026